Detalles de la búsqueda
1.
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.
Blood
; 142(18): 1518-1528, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506339
2.
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.
Haematologica
; 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38031761
3.
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
Blood
; 127(25): 3165-74, 2016 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118453
4.
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM.
Blood
; 127(4): 420-5, 2016 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26500339
5.
Influence of Cognitive Interferences and Self-Talk Functions on Performance During Competition in Elite Female Field Hockey Players.
J Strength Cond Res
; 30(12): 3339-3346, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27050246
6.
Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study.
Br J Haematol
; 190(5): e289-e292, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31792926
7.
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.
Cancers (Basel)
; 16(9)2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38730641
8.
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Br J Haematol
; 162(4): 474-82, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23772672
9.
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.
J Geriatr Oncol
; 14(1): 101401, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404260
10.
The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies.
Biomark Res
; 10(1): 1, 2022 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35000618
11.
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
Int J Hematol
; 115(1): 61-68, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34553338
12.
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM).
Leuk Lymphoma
; 63(14): 3438-3447, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124538
13.
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.
Blood Cancer J
; 12(4): 68, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35440057
14.
The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach.
Diagnostics (Basel)
; 11(11)2021 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34829367
15.
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
J Hematol Oncol
; 14(1): 126, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34404440
16.
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.
Clin Lymphoma Myeloma Leuk
; 21(6): 413-420, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741302
17.
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
Blood Cancer J
; 11(5): 101, 2021 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34021118
18.
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality.
Blood Cancer J
; 10(10): 103, 2020 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077708
19.
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature.
Blood Cancer J
; 9(4): 36, 2019 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30886139
20.
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.
Leukemia
; 33(4): 1056, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30846864